| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 80,402 | 78,926 | 76,439 | 80,455 | | Cost of Revenue | 6,877 | 7,556 | 7,505 | 8,012 | | | Gross Profit | 73,525 | 71,370 | 68,934 | 72,443 | | | Operating Expenses | | Research Development | 12,508 | 9,706 | 8,998 | 11,404 | | Selling General and Administrative | 31,193 | 33,787 | 30,168 | 35,551 | | Non Recurring |
-
| 4 | 52 | 1,523 | | Others | 2,118 | 2,117 | 2,455 | 2,737 | | | | Total Operating Expenses |
-
| 45,614 | 41,673 | 51,215 | | | | Operating Income or Loss | 27,706 | 25,756 | 27,261 | 21,228 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (154) | (537) | (548) | 1,872 | | Earnings Before Interest And Taxes | 27,552 | 25,219 | 26,713 | 23,100 | | Interest Expense | 1,633 | 2,032 | 2,445 | 4,102 | | Income Before Tax | 25,919 | 23,187 | 24,268 | 18,998 | | Income Tax Expense | 6,289 | 6,016 | 5,489 | 169 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,630 | 17,171 | 18,779 | 18,829 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (25) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,630 | 17,171 | 18,779 | 18,804 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,630 | $17,171 | $18,779 | $18,804 |
|
0.02% Nasdaq 0.00%
Income Statement
